Evidence-based medicine

Global Healthcare Artificial Intelligence Market was Estimated to Grow at 25.9% CAGR During the Forecast Period Due to the Rising Adoption of Electronic Patient Registries Creating Potential Datasets for Analytics Using AI: Absolute Markets Insights

Retrieved on:

Thursday, March 5, 2020

Health informatics, Health, Articles, Disease registry, Evidence-based medicine, Healthcare quality, Medical terminology, Registry, Electronic health records

The increasing use of electronic patient registry and medical device registries is leading to generation of potential datasets for application of AI technologies and deriving predictive insights.

Key Points:

The increasing use of electronic patient registry and medical device registries is leading to generation of potential datasets for application of AI technologies and deriving predictive insights.
Electronic patient registry or electronic health record (EHR) are used by hospitals and clinics to collect observational medical data of their patients.
The rising adoption of electronic patient and medical device registry has led to generation of huge datasets which can be optimally utilized for analytical predictive purposes.
Thus, growing digitalization of patient and medical device registries are expected to boost the growth of global healthcare artificial intelligence market globally.

Global Healthcare Artificial Intelligence Market was Estimated to Grow at 25.9% CAGR During the Forecast Period Due to the Rising Adoption of Electronic Patient Registries Creating Potential Datasets for Analytics Using AI: Absolute Markets Insights

Retrieved on:

Thursday, March 5, 2020

Health informatics, Health, Articles, Disease registry, Evidence-based medicine, Healthcare quality, Medical terminology, Registry, Electronic health records

The increasing use of electronic patient registry and medical device registries is leading to generation of potential datasets for application of AI technologies and deriving predictive insights.

Key Points:

The increasing use of electronic patient registry and medical device registries is leading to generation of potential datasets for application of AI technologies and deriving predictive insights.
Electronic patient registry or electronic health record (EHR) are used by hospitals and clinics to collect observational medical data of their patients.
The rising adoption of electronic patient and medical device registry has led to generation of huge datasets which can be optimally utilized for analytical predictive purposes.
Thus, growing digitalization of patient and medical device registries are expected to boost the growth of global healthcare artificial intelligence market globally.

2020 Best in KLAS Report Again Ranks UpToDate from Wolters Kluwer as Category Leader for Clinical Decision Support

Retrieved on:

Tuesday, March 3, 2020

Wolters Kluwer, Health , a leading global provider of trusted clinical technology and evidence-based solutions, today announced that its decision support solution, UpToDate , was ranked number one for clinical decision support (point-of-care clinical reference) in the 2020 Best in KLAS: Software and Services report.

Key Points:

Wolters Kluwer, Health , a leading global provider of trusted clinical technology and evidence-based solutions, today announced that its decision support solution, UpToDate , was ranked number one for clinical decision support (point-of-care clinical reference) in the 2020 Best in KLAS: Software and Services report.
KLAS interviews thousands of healthcare professionals and uses the responses to rate point-of-care and clinical reference tools.
KLASs recognition of UpToDate as a Category Leader again this year is gratifying for us as an organization, said Denise Basow, MD, CEO, Clinical Effectiveness at Wolters Kluwer, Health.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence.

Precision Medicine Market to register over 11% CAGR through 2026: Global Market Insights, Inc.

Retrieved on:

Tuesday, March 3, 2020

Evidence-based medicine, Precision medicine, Systems biology, Market share, Big data, Computing, Systems science, Data

Growing adoption of gene therapy will propel the precision medicine market expansion.

Key Points:

Growing adoption of gene therapy will propel the precision medicine market expansion.
Increasing usage of big data analytics in precision medicine in developing economies will drive the market growth.
Thus, owing to these developments in the region, the precision medicine market will witness significant market growth in the upcoming years.
The market players are adopting strategies such as innovative product launches and acquisitions to expand their customer base and market share.

uniQure to Participate in Multiple Upcoming Industry Conferences in March

Retrieved on:

Tuesday, March 3, 2020

Evidence-based medicine, Precision medicine, Systems biology, Today, American television series, Television in the United States, Television programs

Matt Kapusta , chief executive officer at uniQure, will be presenting a corporate update today, March 3, at 9:20 a.m.

Key Points:

Matt Kapusta , chief executive officer at uniQure, will be presenting a corporate update today, March 3, at 9:20 a.m.
The live webcast of the corporate update can be accessed through the link displayed in the Investor section of the uniQure website .
Members of uniQures management team also will participate in one-on-one investor meetings throughout the day.
In addition, she will participate in the panel discussion Precision Medicine Beyond Oncology on March 31, at 4:30 p.m. GMT.

Elsevier to Showcase Award-winning Clinical Decision Support Solutions at HIMSS20

Retrieved on:

Tuesday, March 3, 2020

Health, Articles, Health informatics, Elsevier, Evidence-based medicine, Medical websites, Online databases, ClinicalKey, Healthcare Information and Management Systems Society, Point of care, Clinical decision support system

Four-year KLAS Category Leader in Clinical Decision Support Care Plans & Order Sets, 'Care Planning' among solutions to be featured

Key Points:

Four-year KLAS Category Leader in Clinical Decision Support Care Plans & Order Sets, 'Care Planning' among solutions to be featured
PHILADELPHIA, March 3, 2020 /PRNewswire/ -- Elsevier , a global leader in information analytics, specializing in science and health, will showcase its clinical decision support solutions at Booth #1859 at the Healthcare Information and Management Systems Society (HIMSS) 2020 annual meeting in Orlando, FL, USA, March 10-12, 2020.
"Through our rich legacy and experience in clinical care, we are able to integrate world-class clinical content at the point of care to better assist healthcare providers," said John Danaher, MD, President, Global Clinical Solutions, Elsevier.
In addition to the virtual panel, Elsevier demonstrations and events at HIMSS20 include:
New Solutions:Elsevier will demonstrate several new solutions, including 3D4Medical , Veridata and PatientPass .
Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect , Scopus , SciVal , ClinicalKey and Sherpath .

Sema4 and VieCure Announce Strategic Collaboration to Accelerate Precision Oncology Care

Retrieved on:

Monday, March 2, 2020

Technology, Genetics, Other Technology, Clinical trials, Software, Biotechnology, Health, Data management, Oncology, Evidence-based medicine, Precision medicine, Systems biology, Oncology, Articles, Workflow, Electronic health record, American Society of Clinical Oncology, Sema4, VieCure

This development will fuel improvements in the diagnosis, treatment, and prevention of cancer through data-driven insights and predictive modeling.

Key Points:

This development will fuel improvements in the diagnosis, treatment, and prevention of cancer through data-driven insights and predictive modeling.
Oncologists are embracing the paradigm shift toward data-driven precision medicine, but they face myriad clinical workflow and content-related challenges, said Fred Ashbury , PhD, Chief Scientific Officer at VieCure.
Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
VieCure has developed a proprietary artificial intelligence informatics software platform in conjunction with a clinical inference engine and smart electronic medical record in oncology.

BC Platforms Appoints Board Member Karen Tay Koh to Accelerate Asia Growth

Retrieved on:

Monday, March 2, 2020

Evidence-based medicine, Precision medicine, Systems biology

ZURICH and BOSTON, March 2, 2020 /PRNewswire/ -- BC Platforms , a world leader in providing powerful genomic data management and analysis solutions,today announced the appointment of Karen Tay Koh to its Board.

Key Points:

ZURICH and BOSTON, March 2, 2020 /PRNewswire/ -- BC Platforms , a world leader in providing powerful genomic data management and analysis solutions,today announced the appointment of Karen Tay Koh to its Board.
BC Platforms' Asia strategy includes a strong precision medicine focus both in healthcare delivery, as well as in genomics-related research.
Karen Tay Koh has long been driven to positively impact human healthcare, from managing hospitals, to setting up medical schools, and advising on healthcare deals.
Tero Silvola, CEO of BC Platforms commented: "We are delighted to welcome Karen to the team.

BC Platforms Appoints Board Member Karen Tay Koh to Accelerate Asia Growth

Retrieved on:

Monday, March 2, 2020

Evidence-based medicine, Precision medicine, Systems biology

ZURICH and BOSTON, March 2, 2020 /PRNewswire/ -- BC Platforms , a world leader in providing powerful genomic data management and analysis solutions,today announced the appointment of Karen Tay Koh to its Board.

Key Points:

ZURICH and BOSTON, March 2, 2020 /PRNewswire/ -- BC Platforms , a world leader in providing powerful genomic data management and analysis solutions,today announced the appointment of Karen Tay Koh to its Board.
BC Platforms' Asia strategy includes a strong precision medicine focus both in healthcare delivery, as well as in genomics-related research.
Karen Tay Koh has long been driven to positively impact human healthcare, from managing hospitals, to setting up medical schools, and advising on healthcare deals.
Tero Silvola, CEO of BC Platforms commented: "We are delighted to welcome Karen to the team.

Seven Bridges Announces Transformative Solution for Analyzing Genomic and Phenotypic Data to Accelerate Novel Drug Development

Retrieved on:

Tuesday, February 25, 2020

Systems biology, Evidence-based medicine, Precision medicine, Bioinformatics

These data have the potential to reveal transformative insights into the underpinnings of disease, novel therapeutic approaches and in silico disease models.

Key Points:

These data have the potential to reveal transformative insights into the underpinnings of disease, novel therapeutic approaches and in silico disease models.
However, current technologies are ill-equipped to effectively handle the scale, complexity and disparate modalities of data being generated by these initiatives.
"Seven Bridges scientists and bioinformaticians have worked closely with researchers to help them interrogate massive datasets to better understand the links between genomic data and health outcomes.
Seven Bridges enables researchers to extract meaningful insights from genomic and phenotypic data in order to advance precision medicine.